Women’s Health Report Assesses first-in-class innovation with focus on endometriosis, polycystic ovarian syndrome and cervical intraepithelial neoplasia

This report assesses first-in-class innovation across the women’s health therapy area, with a particular focus on three key indications: endometriosis, polycystic ovarian syndrome (PCOS) and cervical intraepithelial neoplasia (CIN).

Pune, India - March 14, 2018 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population. Despite this, the women’s health market is relatively small. This reflects diagnostic barriers and high levels of non-treatment for women’s health disorders, as well as high levels of genericization and relatively limited innovation within recent decades.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline
Scope
• Many women’s health disorders are highly prevalent. How do epidemiology trends vary for endometriosis, PCOS and CIN?
• Innovation within women’s health has been relatively limited over recent decades. What are the most prominent unmet needs across this therapy area?
• There are 261 pipeline programs in active development for women’s health. What proportion of these products are first-in-class? How does first-in-class innovation vary by indication, development stage and molecular target class?
• Although the first-in-class pipeline is relatively modest in size it is considerably diverse with eight distinct molecular target classes represented. Which first-in-class targets have been identified as most promising for women’s health conditions?
• Over 200 licensing deals relating to women’s health have been completed since 2006. Do women’s health products typically attract high deal values? Which first-in-class products have prior deal involvement?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/987871
Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of symptoms, epidemiology, etiology, pathophysiology, co-morbidities and complications, diagnosis and treatment options.
• Visualize the composition of the women’s health market in terms of dominant molecule types and molecular targets, highlighting what the current unmet needs are and how they can be addressed. This knowledge allows a competitive understanding of gaps in the current market.
• Analyze the women’s health pipeline and stratify by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising first-in-class targets have been reviewed in greater detail.
• Recognize commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals, and identifying women’s health therapies that have not yet been involved in deals and may offer potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/987871

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/womens-health-report-assesses-first-in-class-innovation-with-focus-on-endometriosis-polycystic-ovarian-syndrome-and-cervical-intraepithelial-neoplasia/314337

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline%20%20

Source: MarketersMedia

Release ID: 314337

Latest News

Malaysia ex-deputy PM charged with graft, money laundering

Oct 19, 2018

KUALA LUMPUR, Malaysia — Malaysia's former deputy prime minister was charged Friday with abuse of power, corruption and money laundering involving millions of dollars in another graft investigation against leaders ousted in elections earlier this year. Ahmad Zahid Hamidi, who now leads the opposition after his party was defeated in the May general elections, was brought to court a day after he was detained by the anti-graft agency. Zahid pleaded not guilty to 10 counts of criminal breach of trust involving nearly 21 million ringgit ($5 million) in his family-run welfare group, eight counts of abusing power as home minister...

Southeast Asian navies to hold drills with China next week

Oct 19, 2018

SINGAPORE — Southeast Asian navies are heading to their first joint exercises with China in its southern waters next week, and defense officials agreed Friday to conduct a similar drill with the U.S. next year. Singapore's Defense Minister Ng Eng Hen said the drills in waters surrounding Zhanjiang will build trust and confidence among the navies participating. The defense ministers of the 10-member Association of Southeast Asian Nations said in a joint declaration their planned exercises would "enhance friendship and confidence between ASEAN member states' navies and the People's Liberation Army Navy and the U.S. Navy." The officials said at...

Malaysia's former deputy PM detained for alleged graft

Oct 19, 2018

PUTRAJAYA, Malaysia — Malaysia's anti-graft agency said Thursday it has detained former Deputy Prime Minister Ahmad Zahid Hamidi in a case linked to misappropriation of funds in a welfare group. Zahid, who now heads the opposition Malay party, is the latest notable person after former Prime Minister Najib Razak and his wife to face graft charges following the shocking ouster of their coalition in May general elections. The anti-graft agency said Zahid was detained at its office shortly after he was summoned as part of its probe into abuse of power, criminal breach of trust and money laundering at a...

World markets steady after earnings-driven rally

Oct 19, 2018

SINGAPORE — Stock markets stabilized Wednesday after a rally inspired by strong corporate earnings, with investors also monitoring talks on Britain's exit from the European Union. KEEPING SCORE: France's CAC 40 added 0.2 percent to 5,183.04 and Britain's FTSE 100 rose 0.3 percent to 7,078.53. Germany's DAX shed 0.3 percent to 11,744.76. U.S. shares were set to open lower as the Dow future contract dropped 0.2 percent to 25,744.00. The broader S&P 500 futures lost 0.1 percent to 2,813.80. ASIA'S DAY: Japan's benchmark Nikkei 225 jumped 1.3 percent to 22,841.12. The Kospi in South Korea advanced 1.0 percent to 2,167.51....

Asian shares climb on strong US corporate earnings, data

Oct 19, 2018

SINGAPORE — Asian markets rose on Wednesday as robust U.S. corporate earnings and encouraging data assuaged worries about softening global growth. KEEPING SCORE: Japan's benchmark Nikkei 225 jumped 1.3 percent to 22,842.12. The Kospi in South Korea advanced 1.1 percent to 2,169.20. The Shanghai Composite rose 0.1 percent to 2,548.88. Australia's S&P/ASX 200 gained 1.2 percent to 5,938.67. Shares rose in Taiwan, Indonesia and Singapore. Markets in Hong Kong were closed for a holiday. WALL STREET: U.S. stocks bounced back from a series of losses, racking up their biggest gain in six months on Tuesday. The S&P 500 index rallied...

Penggerak pasaran mengikut TradingView

About Us

Duniaga is Malaysia’s top local source for business news and information where people head to stay connected with the business news. We give daily in-depth analysis on the business happenings in the country.

Contact us: sales[at]duniaga.com

Subscribe Now!